Placabo
Placabo is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
2
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
3 of 3 finished
0.0%
0 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effect of Zinc Oxide Ointment on Recurrent Aphthous Stomatitis
SAMe for Prevention of Liver Cancer in MASLD-Related Cirrhosis
Effects of Caffeine Ingestion on Morning Cognitive and Muscle Repeated Sprint Performance in Males
To Evaluate the Efficacy and Safety of ALC-2203 in Patients With Acute Bronchitis
Study Comparing Atomizerd Midazolam & Fentanyl and Dexmedomidine for Procedural Sedation in Adult and Pediatric Patient (2 to 60 Years Old)
Clinical Trials (6)
Effect of Zinc Oxide Ointment on Recurrent Aphthous Stomatitis
SAMe for Prevention of Liver Cancer in MASLD-Related Cirrhosis
Effects of Caffeine Ingestion on Morning Cognitive and Muscle Repeated Sprint Performance in Males
To Evaluate the Efficacy and Safety of ALC-2203 in Patients With Acute Bronchitis
Study Comparing Atomizerd Midazolam & Fentanyl and Dexmedomidine for Procedural Sedation in Adult and Pediatric Patient (2 to 60 Years Old)
2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled Asthma
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6